Here we present a protocol to efficiently isolate primary human keratinocytes from adult skin tissues. This method simplifies the conventional procedure by using the ROCK Inhibitor Y-27632 in the inoculation medium to spontaneously separate epidermal cells from dermal cells.
Primary human keratinocytes isolated from fresh skin tissues and their expansion in vitro have been widely used for laboratory research and for clinical applications. The conventional isolation method of human keratinocytes involves a two-step sequential enzymatic digestion procedure, which has been proven to be inefficient in generating primary cells from adult tissues due to the low cell recovery rate and reduced cell viability. We recently reported an advanced method to isolate human primary epidermal progenitor cells from skin tissues that utilizes the Rho kinase inhibitor Y-27632 in the medium. Compared with the traditional protocol, this new method is simpler, easier, and less time-consuming, and increases epithelial stem cell yield and enhances their stem cell characteristics. Moreover, the new methodology does not require the separation of the epidermis from the dermis, and, therefore, is suitable for isolating cells from different types of adult tissues. This new isolation method overcomes the major shortcomings of conventional methods and is more suitable for producing large numbers of epidermal cells with high potency both for laboratory and for clinical applications. Here, we describe the new method in detail.
The goal was to develop a simple and efficient protocol to isolate primary human keratinocytes (HKCs) from adult tissues, especially for clinical applications. Skin epidermal stem cells, localized in the basal layer of the skin, possess a high potential to proliferate and differentiate and provide keratinocytes to maintain the functions of the skin1,2,3,4. HKCs isolated from skin tissues are widely used for skin tissue engineering and regeneration purposes, especially in the repair of damaged skin and in gene therapy for clinical applications5,6. The key issue for HKC-based applications is to efficiently isolate and expand large numbers of HKCs with high potential in vitro7,8. Although various research groups have developed methods to produce cultures of stem-like HKCs, these methods are sometimes time-consuming and complicated to perform and have other limitations, such as low cell yields and being limited by the type of skin specimen used9. For instance, the traditional method to isolate HKCs from skin tissues involves a two-step enzymatic digestion with a separation of the epidermis from the dermis6. That method usually works well for neonatal tissues, but it becomes very difficult when used to isolate cells from adult tissues.
Y-27632, an inhibitor of Rho-associated protein kinase (ROCK), has been reported to significantly enhance the efficiency of epidermal stem cell isolation and colony growth10,11,12. In a previous study, we discovered that Y-27632 facilitates the clonal growth of epidermal cells but reduces the yield of dermal cells by differentially controlling the expression of adhesion molecules13. We also established a new conditioned inoculation medium, called G-medium, which supports the growth and yield of primary epidermal cells. By combining G-medium with Y-27632, this novel method can spontaneously separate epidermal and dermal cells after enzyme digestion, thus removing the step of epidermis-dermis separation13,14. Based on previous reports, we now describe the detailed procedure of this new method to isolate HKCs from adult skin tissue.
Human tissues used in this protocol have been handled according to the guidelines of the Institution's human research ethics committee (NO.2015120401, date: May 12, 2015).
1. Preparations
2. Conventional Method
3. The New Method
4. Cell Passaging
Schematic diagrams of the new method (Figure 1A) and the conventional method (Figure 1B) are presented in Figure 1. The conventional method is a two-step digestion, which requires a 2-day procedure. By contrast, the new method is a one-step digestion, which takes around 3 hours to perform. Importantly, the one-step new method can obtain two populations (epidermal and dermal cells) at the same time, which depends on the presence of Y-27632 in the inoculation medium. Moreover, the initial culture time of epidermal cells to reach around 80% confluence usually takes at least 3 days less than the conventional method if the same number of cells is inoculated after isolation.
The new method yields more primary epidermal cells, which grow in a colony morphology. The isolated HKCs from human skin tissues were inoculated with G-medium containing Y-27632. The same number of cells were plated following the conventional method as the control. Representative images of the epidermal cells at days 3 and 5 after the initial inoculation are shown in Figure 2A. The cells obtained from the new method tended to grow as a colony morphology. The growth curve after inoculation was assessed using a cell counting kit-8 (CCK-8) at different time points after inoculation (Figure 2B), and the doubling time is around 3 – 4 days for cells prepared by the new method but is around 6 – 8 days for the conventional method. At day 7, the yields of the cells were calculated. The results are shown in Figure 2C, which shows that the new method yielded three times more cells than the conventional method and that the time needed to reach confluence after the initial inoculation was at least 3 days less (Figure 2D). At day 7, the epidermal cells reached confluence with the new method, but not with the conventional method (Figure 2D).
The new method enhanced the expression of α6-integrin by the primary cells. α6-integrin has been shown to be highly expressed by epidermal stem cells15. Cells isolated by the new method maintained the characteristics of skin basal cells after several passages. Colony growth is one of the characteristics of epidermal stem cells derived from the basal layer of the skin, and a high level of α6-integrin expression is another feature of these epidermal stem cells. We found that the addition of Y-27632 significantly increased the expression of α6-integrin in epidermal cells at passage 3 (Figure 3A-B), and at passage 3, epidermal cells isolated using the new method show no contamination by dermal cells13. It is very important to maintain the basal cell features after several passages during in vitro expansion. Immunofluorescence (IF) analysis of the basal cell marker keratin 5 and the terminal differentiation marker loricrin16 was performed with those cells after three passages. We found that 90% of all cells were K5-positive but less than 10% of them expressed loricrin (Figure 3C – 3D). These results indicate that primary HKCs isolated using the new method contain an epidermal stem cell population and can maintain the characteristic features of basal cells. But the longer that HKCs are passaged, the more they begin to differentiate. By the new method, we found that epidermal cells cultured in vitro could maintain their proliferation ability until passage 8. Finally, we tested the purity of epidermal cells isolated using the new method, since a mixture of epidermal and dermal cells was inoculated right after isolation. With a short-time (2 – 3 min) treatment with trypsin to remove a few dermal cells contaminating the initial culture, a relatively pure population of epidermal cells was obtained after one passage (Figure 4).
Figure 1: Comparison of the new and conventional isolation procedures. (A) This panel shows a schematic representation of the new isolation method. At day 1, the dissociated skin cells are inoculated in G-medium with or without Y-27632. In the presence of Y-27632 for 2 days, the epidermal cells selectively expand. At around day 6, the cells reach a density sufficient enough for passaging. (B) This panel shows a schematic representation of the conventional isolation method. The epidermis is separated from the dermis and the epidermal cells are isolated on day 2, and usually, the cells reach a density sufficient enough for passaging at around 10 days. Please click here to view a larger version of this figure.
Figure 2: The new isolation method increases the yield of primary epidermal cells. (A) This panel shows representative images of epidermal cells prepared by the new method (top row) and by the conventional method (bottom row) at days 3 and 5 after the initial inoculation. The scale bars = 200 µm. (B) Primary HKCs prepared by the new and the conventional methods were collected at the indicated time points for the analysis of viable cells using a cell counting kit-8 (CCK-8). (C) The total number of cells prepared by the new method and by the conventional method were counted at day 7 after inoculation. (D) The average time to reach confluence of primary epidermal cells (passage 0) is shown for both the new isolation method and the conventional method. For panels B – D: Student's t-test was used; the error bars show the standard variation; n = 4; ** p < 0.01, * p < 0.05 when comparing the new method with the conventional method. Please click here to view a larger version of this figure.
Figure 3: Primary epidermal cells obtained by the new method are able to maintain basal cell features during in vitro expansion. (A) This panel shows an FACS analysis of α6-integrin expression of epidermal cells at passage 3 treated with Y-27632 (Y-27632, red) or without Y-27632 (control, grey) for 48 h. (B) This panel shows a quantification analysis of cells with high expression levels of α6-integrin from panel A; high α6-integrin expression is defined as a signal > 103, ** p < 0.01. (C) This panel shows representative images of immunofluorescence staining of K5 (red) and loricrin (red); DAPI (blue) was used to stain nuclei. The scale bars = 100 µm. (D) This panel shows a quantification analysis of K5- and loricrin-positive cells. A total of 400 cells were counted to quantify each group, and the average numbers of K5- and loricrin-positive cells are shown. The experiment was independently repeated 4 times. Please click here to view a larger version of this figure.
Figure 4: After the initial passage, relatively pure epidermal cells were obtained using the new method. (A) This panel shows representative images of immunofluorescence staining of vimentin (red) for epidermal cells at passages 0 (P0) and 3 (P3); DAPI (blue) was used to stain nuclei. The scale bars = 50 µm. (B) This panel shows a quantification analysis of vimentin-positive cells at passages 0 (P0) and 1 (P1). A total of 400 cells were counted to quantify each group, and the average number of vimentin-positive cells is shown. The experiment was independently repeated 4 times. Please click here to view a larger version of this figure.
Cultured primary HKCs have been widely utilized to treat wounds in clinics for more than three decades and, since that time, it has been always important to efficiently obtain sufficient numbers of cells for clinical applications in a timely manner. Therefore, in practice, the conventional isolation method, which requires the separation of the epidermis from the dermis, makes it difficult to meet these demands, due to the low yield of cells and the low ability to passage adult cells. Here, we describe a new simple method we developed to efficiently obtain HKCs from adult tissue based on previous reports13,14, which is more suitable both for laboratory and for clinical applications.
Attention must be paid to the following critical steps to achieve the best results for the new method. First, the homogenization procedure is a crucial step; insufficient homogenization will clearly affect the efficiency of enzymatic digestion and result in a low yield of dissociated cells. Second, the trypsin digestion step should not take more than 30 min; otherwise, the viability of the dissociated cells will decrease. Third, to efficiently collect the dissociated cells, the pore size of the cell strainer used for filtration should be 100 µm, and a single strainer should be used to filter no more than 20 mL of the cell solution. Fourth, the density of the initial plating is an important factor to minimize contamination with dermal cells, because a high cell density will significantly reduce the inhibitory effect of Y-27632 on dermal cells. Therefore, it is crucial to accurately count the total number of dissociated cells at the end of the isolation procedure before plating.
First, the new method simplifies the isolation procedure: the two-step conventional isolation procedure usually takes 2 days to perform, and the trimming procedure is crucial to completely remove the fat tissue from the skin, especially for adult tissues (Figure 1); otherwise, there will be an inefficient separation of the epidermis from the dermis after overnight digestion with dispase. By taking advantage of Y-27632, which inhibits the growth of dermal cells after inoculation13, the new method does not need to separate the epidermis from the dermis and, therefore, the trimming procedure to remove the fat tissue is not necessary for the new method, which only needs half a day to be performed. Second, the new method also simplifies the culture procedure since, with the traditional method, the dissociated cells are usually cultured on a feeder layer of irradiated mouse fibroblasts in medium containing 10% FBS or in a collagen-precoated dish. Animal-derived components are always risk factors that should be avoided for clinical applications. We developed a serum-free conditioned inoculation medium (G-medium), which does not require a precoating step for culture dishes and also enhances the yield of primary keratinocytes13 because G-medium combined with Y-27632 promotes the attachment of epidermal cells to the culture dish13,17,18. Therefore, the new method facilitates the culture procedure and is also a relatively safe procedure for clinical applications without the addition of animal-derived components. Third, the new method improves the yield of primary epidermal cells and shortens the initial culture time needed to reach confluence. Compared with the traditional method, the yield of cells produced by the new method is around 3 times higher, and the initial passage of epidermal cells reached confluence at least 3 days earlier (Figure 2). Finally, the new method can be utilized for the isolation of epidermal cells from all types of skin specimens, such as hairy scalp skin and adult skin tissues with a thick fat layer, which have been tested in a previous report13.
High-potential primary HKCs have been widely used for laboratory research and for clinical applications. This new method enhances the potential of cultured cells with characteristics of epidermal stem cells13. Y-27632 enhances the α6-integrin expression by HKCs, and after three passages, more than 90% of the cultured epidermal cells expressed the basal cell marker keratin 5, and fewer than 10% of the cells expressed the differentiation marker Loricrin, indicating that these cells keep the characteristics of skin basal cells after several passages. The culture-expanded epidermal cells can reconstitute skin in vivo after grafting13, suggesting that they possess regeneration potential after expansion in culture. Notably, the new method is ideal to isolate cells from adult tissues, as mentioned above. Therefore, epidermal cells prepared by this method can be used for in vitro and in vivo models to study skin diseases and can be developed into autologous cell-based products for clinical applications such as the treatment of skin wounds.
In summary, the new protocol provides a simplified and effective procedure to isolate and expand primary epidermal cells from adult skin tissue. This advanced method is more suitable for producing large numbers of high-potential epidermal cells both for laboratory and for clinical applications.
The authors have nothing to disclose.
This work was supported by the National Key Research and Development Program of China (2017YFA0104604), the General Program of National Natural Science Foundation of China (NSFC, 81772093), the Science and Technology Development Program of Suzhou (ZXL2015128), the Natural Science Foundation of Jiangsu Province (BK20161241), and a Shandong Taishan Scholar Award (tshw201502065).
Countess automated cell counter | Invitrogen Inc. | C10227 | Automatic cell counting |
CO2 Incubator | Thermo Scientific | 51026333 | For cell incubating |
Sorvall ST 16R Centrifuge | Thermo Scientific | 75004380 | Cell centrifuge |
Constant Temperature Shaker | Shanghai Boxun | 150036 | For water bath |
Electronic Scale | Harbin Zhonghui | 1171193 | For tissue weighing |
Cell Culture Dish | Eppendorf | 30702115 | For cell culture |
50ml Centrifuge Tube | KIRGEN | 171003 | For cell centrifuge |
Cell Strainer | Corning incorporated | 431792 | Cell filtration |
Phosphate buffered solution | Solarbio Life Science | P1020-500 | Washing solution |
DMEM | Thermo Scientific | C11995500 | Component of neutralization medium |
Defined K-SFM | Life Technologies | 10785-012 | Epidermal cells culture medium |
Penicillin Streptomycin | Thermo Scientific | 15140-122 | Antibiotics |
Fetal Bovine Serum | Biological Industries | 04-001-1AC5 | Component of neutralization medium |
0.05% Trypsin | Life Technologies | 25300-062 | For HKC dissociation |
0.25% Trypsin | Beijing Solarbio Science & Technology | T1350-100 | For HKC dissociation |
Coating Matrix Kit | Life Technologies | R-011-K | For coating matrix |
Dispase | Gibco | 17105-041 | For HKC isolation |
Collagenase Type I | Life Technologies | 17100-017 | For HKC isolation |
Deoxyribonuclease I | Sigma | 9003-98-9 | For HKC isolation |
F12 Nutrient Mix, Hams | Life Technologies | 31765035 | Component of G-medium |
B27 Supplement | Life Technologies | 17504044 | Growth factor in G-medium |
FGF-2 Millipore | Merck Biosciences | 341595 | Growth factor in G-medium |
Y-27632 | Sigma-Aldrich | Y0503 | ROCK inhibitor |
Fungizone | Gibco | 15290026 | Preparation for G-medium |
EGF Recombinant Human Protein | Gibco | PHG0311 | Growth factor in G-medium |
Cell Counting Kit-8 | Thermo Scientific | NC9864731 | cell proliferation and cytotoxicity assays |
Mouse Anti-Human Cytokeratin5 | Hewlett-Packard Development Company | MA-20142 | For immunofluorescence staining to check differentiation marker of HKCs |
Rabbit Anti-Human Loricrin | Covance | PRB-145p | For immunofluorescence staining to check differentiation marker of HKCs |
Mouse anti-human Vimentin | Cell Signaling Technology | 3390 | For immunofluorescence staining of dermal fibroblasts |
Integrin α6(GOH3) | Santa Cruz | SC-19622 | flow cytometry analysis of HKCs |
Rat IgG2a FITC | Santa Cruz | SC-2831 | negative control antibody of α6-integrin in flow cytometry analysis |